Goods & Services

Topical Anti-Inflammatory Preparation

Abstract

The present invention comprises packaged enemas for the treatment of Inflammatory Bowel Disease (IBD), having substantially pure 5-ASA as the active ingredient, with a liquid carrier medium having a material avoidance of bowel irritant substances, such as anti-oxidants for the 5-ASA active ingredient, including such sulfites as potassium metabisulfite, for example, and contained within a sealed and substantially oxygen-free barrier package, which may preferably be formed of a foil/polymer laminate, and which package contains or otherwise includes an oxygen scavenger, such as a an oxygen scavenging sachet.

IPC Classes  ?

• A01N 33/02 - AminesQuaternary ammonium compounds
• A01N 33/18 - Nitro compounds

Abstract

The present invention comprises packaged enemas for the treatment of Inflammatory Bowel Disease (IBD), having substantially pure 5-ASA as the active ingredient, with a liquid carrier medium having a material avoidance of bowel irritant substances, such as anti-oxidants for the 5-ASA active ingredient, including such sulfites as potassium metabisulfite, for example, and contained within a sealed and substantially oxygen-free barrier package, which may preferably be formed of a foil/polymer laminate, and which package contains or otherwise includes an oxygen scavenger, such as a an oxygen scavenging sachet.

IPC Classes  ?

• A01N 33/02 - AminesQuaternary ammonium compounds
• A01N 33/24 - Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds containing nitrogen-to-oxygen bonds only one oxygen atom attached to the nitrogen atom

Abstract

The present invention comprises packaged enemas for the treatment of Inflammatory Bowel Disease (IBD), having substantially pure 5-ASA as the active ingredient, with a liquid carrier medium having a material avoidance of bowel irritant substances, such as anti-oxidants for the 5-ASA active ingredient, including such sulfites as potassium metabisulfite, for example, and contained within a sealed and substantially oxygen-free barrier package, which may preferably be formed of a foil/polymer laminate, and which package contains or otherwise includes an oxygen scavenger, such as a an oxygen scavenging sachet.

IPC Classes  ?

• A01N 33/02 - AminesQuaternary ammonium compounds
• A01N 33/18 - Nitro compounds

Goods & Services

Medicated and pharmaceutical preparations, [both] prescription [and non-prescription,] specifically, pharmaceutical preparations for the treatment of [vascular diseases, dementia, cognitive impairment,] anemia, gastrointestinal diseases, [osteoporosis, micronutrient deficiencies,] colic, acute rhinitis, parkinsonism, and poisoning by anticholinesterase agents[; pharmaceutical preparations for bowel cleansing; and, dietary and nutritional supplements]

Goods & Services

PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF GASTROINTESTINAL DISEASES

Goods & Services

Pharmaceuticals, namely, iron supplements

Goods & Services

Pharmaceuticals, namely, pre-natal vitamins with iron

Goods & Services

PHARMACEUTICAL PREPARATION TO TREAT GASTROINTESTINAL AND/OR UROLOGICAL DISORDERS

Goods & Services

anticholinergic and antispasmodic pharmaceutical preparations

Goods & Services

PHARMACEUTICAL PREPARATION SUITABLE FOR THE TREATMENT OF GASTROINTESTINAL DISEASES

Goods & Services

a Medicinal Compound Used in the Treatment of Various Gastrointestinal [ and Rheumatoid ] Disorders

Goods & Services

ULCERATIVE COLITIS AND ULCERATIVE PROCTITIS TREATMENT

Goods & Services

PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF PROCTOLOGICAL DISORDERS

Goods & Services

Steroid Hormones

Goods & Services

ANTICHOLINERGIC AGENT FOR REDUCING GASTRO-INTESTINAL MOTILITY, DECREASING GASTRIC SECRETORY ACTIVITY, AND EXERTING PARASYMPATHOLYTIC ACTION IN VISCERAL SMOOTH MUSCLE AND GLANDS USED IN THE TREATMENT OF GASTRO-INTESTINAL SPASTICITIES, PYLOROSPASM, PEPTIC ULCER, BILIARY COLIC AND BILIARY DYSFUNCTION, [ DYSMENORRHEA, ] GENITOURINARY SPASM, OR IN OTHER CONDITIONS IN WHICH HYPER-TONICITY OF SMOOTH MUSCLE OCCURS